You have 9 free searches left this month | for more free features.

CC-401

Showing 1 - 25 of 1,116

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Volunteers Trial in Leuven (CC-97489, [18F]T-401, [11C]MK-3168)

Recruiting
  • Healthy Volunteers
  • Leuven, Belgium
  • +1 more
Oct 19, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (CC-90009, Venetoclax, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • San Francisco, California
  • +25 more
Jan 9, 2023

Multiple Myeloma Trial in Worldwide (CC-99712, BMS-986405)

Recruiting
  • Multiple Myeloma
  • La Jolla, California
  • +38 more
Jan 3, 2023

Leukemia, Myeloid Trial in Worldwide (CC-90011, Venetoclax, Azacitidine)

Completed
  • Leukemia, Myeloid
  • Duarte, California
  • +34 more
Apr 26, 2022

Tumors Trial in Worldwide (CC-95251, Rituximab, Cetuximab)

Recruiting
  • Neoplasms
  • Birmingham, Alabama
  • +62 more
Jan 19, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Rituximab, Obinutuzumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Los Angeles, California
  • +86 more
Jan 23, 2023

Multiple Myeloma Trial in Worldwide (CC-220, Dexamethasone, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +126 more
Jan 10, 2023

Dermatitis, Atopic, Eczema Trial in Worldwide (CC-93538, Placebo)

Completed
  • Dermatitis, Atopic
  • Eczema
  • Birmingham, Alabama
  • +156 more
Dec 12, 2022

Acromioclavicular Joint Dislocation Trial in Chon Buri (K-wire)

Recruiting
  • Acromioclavicular Joint Dislocation
  • K-wire
  • Chon Buri, Thailand
    Queen Savang Vadhana Memorial Hospital
May 2, 2023

Multiple Myeloma Trial in Duarte, Boston, Portland (SL-401/ Pomalidomide/ Dexamethasone)

Terminated
  • Multiple Myeloma
  • SL-401/ Pomalidomide/ Dexamethasone
  • Duarte, California
  • +2 more
Jan 13, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-96673)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Minneapolis, Minnesota
  • +11 more
Nov 18, 2022

Angioimmunoblastic T-cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Follicular T-Cell Lymphoma Trial in United States

Recruiting
  • Angioimmunoblastic T-cell Lymphoma
  • +6 more
  • Los Angeles, California
  • +20 more
Aug 2, 2022

Hypercholesterolemia Trial in Sydney, Morayfield, Melbourne (VXX-401, Placebo)

Recruiting
  • Hypercholesterolemia
  • Sydney, New South Wales, Australia
  • +2 more
Mar 15, 2023

Multiple Sclerosis Trial in Stockholm (Temelimab 18 mg/kg, Temelimab 36mg/kg, Temelimab 54 mg/kg)

Terminated
  • Multiple Sclerosis
  • Temelimab 18 mg/kg
  • +2 more
  • Stockholm, Sweden
    Center for Neurology, Academic Specialist Center
Jul 4, 2022

Rett Syndrome Trial in Aurora, Boston, Houston (NGN-401)

Recruiting
  • Rett Syndrome
  • NGN-401
  • Aurora, Colorado
  • +2 more
Jun 12, 2023

Pulmonary Hypertension, Interstitial Lung Disease Trial (LIQ861)

Not yet recruiting
  • Pulmonary Hypertension
  • Interstitial Lung Disease
  • LIQ861
  • (no location specified)
Nov 10, 2023

Hearing Loss Trial in Melbourne (SENS-401 (R-Azasetron Besylate))

Recruiting
  • Hearing Loss
  • SENS-401 (R-Azasetron Besylate)
  • Melbourne, Australia
    Royal Victorian Eye and Ear Hospital
Jul 8, 2022

Non-Hodgkin Lymphoma Trial (CC-122, Dexamethasone)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • (no location specified)
Jan 10, 2023

Detection and Characterization of Host Defense Defects

Recruiting
  • Immune Defects
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Diabetic Macular Edema Trial (K8)

    Not yet recruiting
    • Diabetic Macular Edema
    • (no location specified)
    Jan 27, 2023

    Cervical Cancer Trial (Game Changers for Cervical Cancer Prevention)

    Not yet recruiting
    • Cervical Cancer
    • Game Changers for Cervical Cancer Prevention
    • (no location specified)
    Aug 17, 2023

    Ulcerative Colitis Trial in Worldwide (BBT-401-1S, Placebo)

    Completed
    • Ulcerative Colitis
    • Little Rock, Arkansas
    • +31 more
    Oct 18, 2022

    Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)

    Active, not recruiting
    • Lymphoma, Large B-Cell, Diffuse
    • Santa Barbara, California
    • +22 more
    Jan 25, 2023

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +6 more
    • Tucson, Arizona
    • +23 more
    Dec 14, 2021

    Infections and Infection Susceptibility

    Recruiting
    • Immune Deficiencies
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023